Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • No Records Found
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Transition of Care in VTE
    Release Date:
    Anticoagulation Education - NVAF or VTE
    Release Date:
    Review Process:
    Achievement of Treat-to-Target in Rheumatoid Arthritis
    Release Date:
    Improving Care of Chronic Pain- Physician Groups and Health Systems
    Release Date:
    Facilitation of the Diagnosis of Rheumatoid Arthritis
    Release Date:
    Pfizer and NCCN: Metastatic Breast Cancer
    Release Date:
    Pediatric Immunization Series Completion
    Release Date:
    Pfizer and National Psoriasis Foundation (NPF): Plugging the Treatment Gap in Psoriasis and Psoriatic Arthritis
    Release Date:
    Pfizer and International Atherosclerosis Society (IAS): Lipid Management in High-Risk Patients
    Release Date:
    Pfizer and American Academy of Dermatology (AAD): Patient Access to Care
    Release Date:
    Narrowing the Time Gap between Onset of Symptoms and Treatment for Rheumatoid Arthritis
    Release Date: